BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9356732)

  • 1. Purinergic transmitters inhibit bone formation by cultured osteoblasts.
    Jones SJ; Gray C; Boyde A; Burnstock G
    Bone; 1997 Nov; 21(5):393-9. PubMed ID: 9356732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling.
    Hoebertz A; Mahendran S; Burnstock G; Arnett TR
    J Cell Biochem; 2002; 86(3):413-9. PubMed ID: 12210747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular nucleotides potentiate the cytosolic Ca2+, but not cyclic adenosine 3', 5'-monophosphate response to parathyroid hormone in rat osteoblastic cells.
    Kaplan AD; Reimer WJ; Feldman RD; Dixon SJ
    Endocrinology; 1995 Apr; 136(4):1674-85. PubMed ID: 7895678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of the longitudinal muscle and the muscularis mucosae of the rat duodenum to adenine and uracil nucleotides.
    Johnson CR; Charlton SJ; Hourani SM
    Br J Pharmacol; 1996 Mar; 117(5):823-30. PubMed ID: 8851497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
    Koh AJ; Beecher CA; Rosol TJ; McCauley LK
    Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective stimulation of catecholamine release from bovine adrenal chromaffin cells by an ionotropic purinergic receptor sensitive to 2-methylthio ATP.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():41. PubMed ID: 17584495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
    Ho C; Hicks J; Salter MW
    Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses.
    Evans RJ; Kennedy C
    Br J Pharmacol; 1994 Nov; 113(3):853-60. PubMed ID: 7858877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular ATP increases [Ca2+]i in primarily cultured pig coronary smooth muscle cells via a P2Y purinoceptor subtype.
    Seiler L; Matyas S; Fleckenstein-Grün G
    J Cardiovasc Pharmacol; 1999 May; 33(5):807-13. PubMed ID: 10226870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.
    von Kügelgen I; Späth L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):187-96. PubMed ID: 1448182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct P2 purinergic receptors, P2Y and P2U, are coupled to phospholipase C in mouse pineal gland tumor cells.
    Suh BC; Son JH; Joh TH; Kim KT
    J Neurochem; 1997 Apr; 68(4):1622-32. PubMed ID: 9084434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a P2X7 receptor by a subpopulation of human osteoblasts.
    Gartland A; Hipskind RA; Gallagher JA; Bowler WB
    J Bone Miner Res; 2001 May; 16(5):846-56. PubMed ID: 11341329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization of the P2-purinoceptors on the rat colon muscularis mucosae.
    Hourani SM; Johnson CR; Bailey SJ
    Br J Pharmacol; 1993 Sep; 110(1):501-5. PubMed ID: 8220915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contractile effects of uridine 5'-triphosphate in the rat duodenum.
    Johnson CR; Hourani SM
    Br J Pharmacol; 1994 Dec; 113(4):1191-6. PubMed ID: 7889272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2 purinoceptor localization along rat nephron and evidence suggesting existence of subtypes P2Y1 and P2Y2.
    Cha SH; Sekine T; Endou H
    Am J Physiol; 1998 Jun; 274(6):F1006-14. PubMed ID: 9841490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.
    Rubino A; Burnstock G
    Br J Pharmacol; 1996 Jul; 118(6):1415-20. PubMed ID: 8832066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTH(1-34) suppresses appositional bone formation by cultured rat cranial osteoblasts.
    Gray C; Jones SJ
    Bone; 1998 Nov; 23(5):453-7. PubMed ID: 9823452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblast-like cells have a variable mixed population of purino/nucleotide receptors.
    Yu H; Ferrier J
    FEBS Lett; 1993 Aug; 328(1-2):209-14. PubMed ID: 8344428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+ response of rat mesangial cells to ATP analogues.
    Gutierrez AM; Lou X; Erik A; Persson G; Ring A
    Eur J Pharmacol; 1999 Mar; 369(1):107-12. PubMed ID: 10204688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.